Wave Life Sciences Stock Performance
| WVE Stock | USD 13.49 0.33 2.51% |
Wave Life holds a performance score of 8 on a scale of zero to a hundred. The firm maintains a market beta of -2.2, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Wave Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Wave Life is expected to outperform it. Use Wave Life Sciences semi variance, as well as the relationship between the daily balance of power and period momentum indicator , to analyze future returns on Wave Life Sciences.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.51 | Five Day Return 2.51 | Year To Date Return (15.42) | Ten Year Return (5.60) | All Time Return (15.69) |
1 | Disposition of 42000 shares by Henry Christian O of Wave Life at 5.97 subject to Rule 16b-3 | 12/19/2025 |
2 | Danaher Corp Q4 2025 Earnings Call Highlights Strong Finish with Robust Free Cash Flow ... | 01/28/2026 |
3 | The Year Strategy Meets Scale Brillios Beyond the Curve 2026 Charts the Enterprise AI Roadmap | 02/03/2026 |
4 | BD stock slips despite Q1 FY26 beat | 02/09/2026 |
5 | Respiratory Care Devices Market to Reach 47.9 billion, Globally, by 2033 at 7.6 percent CAGR Allied Market Research | 02/12/2026 |
6 | ETHZilla offers token tied to jet engine leases amid tokenization pivot | 02/13/2026 |
7 | Undiscovered European Gems To Explore This February 2026 | 02/17/2026 |
8 | Angioplasty Balloons Market to Reach 3.6 Billion, Globally, by 2033 at 3.4 percent CAGR Allied Market Research | 02/18/2026 |
9 | Two Male Birth Control Options Advance Into Phase II Clinical Trials | 02/19/2026 |
| Begin Period Cash Flow | 204.1 M | |
| Total Cashflows From Investing Activities | -938 K |
Wave Life Relative Risk vs. Return Landscape
If you would invest 746.00 in Wave Life Sciences on November 23, 2025 and sell it today you would earn a total of 603.00 from holding Wave Life Sciences or generate 80.83% return on investment over 90 days. Wave Life Sciences is generating 2.0375% of daily returns assuming volatility of 19.6054% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Wave, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Wave Life Target Price Odds to finish over Current Price
The tendency of Wave Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 13.49 | 90 days | 13.49 | about 47.02 |
Based on a normal probability distribution, the odds of Wave Life to move above the current price in 90 days from now is about 47.02 (This Wave Life Sciences probability density function shows the probability of Wave Stock to fall within a particular range of prices over 90 days) .
Wave Life Price Density |
| Price |
Predictive Modules for Wave Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Wave Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Wave Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Wave Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Wave Life is not an exception. The market had few large corrections towards the Wave Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Wave Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Wave Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.08 | |
β | Beta against Dow Jones | -2.2 | |
σ | Overall volatility | 3.74 | |
Ir | Information ratio | 0.1 |
Wave Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Wave Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Wave Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (65.38 M). | |
| Wave Life Sciences has about 148.16 M in cash with (151.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 86.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach |
Wave Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Wave Stock often depends not only on the future outlook of the current and potential Wave Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Wave Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 138.3 M | |
| Cash And Short Term Investments | 302.1 M |
Wave Life Fundamentals Growth
Wave Stock prices reflect investors' perceptions of the future prospects and financial health of Wave Life, and Wave Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wave Stock performance.
| Return On Equity | -0.87 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (1.12) % | ||||
| Operating Margin | (7.41) % | ||||
| Current Valuation | 2.18 B | ||||
| Shares Outstanding | 185.76 M | ||||
| Price To Earning | (6.50) X | ||||
| Price To Book | 18.91 X | ||||
| Price To Sales | 22.38 X | ||||
| Revenue | 108.3 M | ||||
| Gross Profit | (65.38 M) | ||||
| EBITDA | (101.74 M) | ||||
| Net Income | (97.01 M) | ||||
| Cash And Equivalents | 148.16 M | ||||
| Cash Per Share | 1.71 X | ||||
| Total Debt | 25.4 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 2.50 X | ||||
| Book Value Per Share | 0.78 X | ||||
| Cash Flow From Operations | (151.03 M) | ||||
| Earnings Per Share | (0.65) X | ||||
| Market Capitalization | 2.44 B | ||||
| Total Asset | 352.21 M | ||||
| Retained Earnings | (1.12 B) | ||||
| Working Capital | 209.44 M | ||||
| Current Asset | 161.38 M | ||||
| Current Liabilities | 3.82 M | ||||
About Wave Life Performance
By analyzing Wave Life's fundamental ratios, stakeholders can gain valuable insights into Wave Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Wave Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Wave Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 22.91 | 20.36 | |
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.53) | (0.55) | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | (0.42) | (0.44) |
Things to note about Wave Life Sciences performance evaluation
Checking the ongoing alerts about Wave Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wave Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (65.38 M). | |
| Wave Life Sciences has about 148.16 M in cash with (151.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 86.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach |
- Analyzing Wave Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wave Life's stock is overvalued or undervalued compared to its peers.
- Examining Wave Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wave Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wave Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wave Life's stock. These opinions can provide insight into Wave Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |